Autophagy-related biological targets and network mechanisms of juglone against bladder cancer Yuanfeng ZhangEnguang YangZhiping Wang Research Open access 21 June 2025 Article: 194
Mesenchymal stem cells in the bone marrow microenvironment: a double-edged sword for AML Mohamed J. SaadhNima Torabi FardHamed Soleimani Samarkhazan Review Open access 21 June 2025 Article: 193
The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer – the SERAPHINA study Andreas SchneeweissPeter A. FaschingAndreas D. Hartkopf Research Open access 19 June 2025 Article: 192
Treatment with gemcitabine/cisplatin and durvalumab for advanced biliary tract cancer – real-world data from a multicenter German patient population Florian GerhardtChristian MüllerFlorian van Bömmel Research Open access 18 June 2025 Article: 191
Development and interpretation of machine learning-based prognostic models for predicting high-risk prognostic pathological components in pulmonary nodules: integrating clinical features, serum tumor marker and imaging features Dingxin WangJianhao QiuHui Tian Research Open access 17 June 2025 Article: 190
Sit to stand is a new reliable method for assessing strength, power, and velocity exercise in adult pediatric cancer survivors Ángela Rodríguez-PereaDaniel Jerez-MayorgaLuis Gracia-Marco Research Open access 14 June 2025 Article: 189
Pharmacokinetic bioequivalence of the fixed-dose combination of pertuzumab and trastuzumab administered subcutaneously using a handheld syringe or an on-body delivery system Chris WynneBei WangEleonora Restuccia Research Open access 14 June 2025 Article: 188
Time to breast cancer recurrence and associated predictors in Public Hospitals of Addis Ababa, Central Ethiopia: a retrospective Cohort Study Yadessa ChalaTesfaye TechaneAlem Deksisa Research Open access 12 June 2025 Article: 187
Radiogenomic correlation of hypoxia-related biomarkers in clear cell renal cell carcinoma Yijun ShaoHarmony S. CenVinay A. Duddalwar Research Open access 12 June 2025 Article: 186
From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspective Armando Orlandi Correspondence Open access 09 June 2025 Article: 185
Radiopharmaceutical application of TRK-950, an anti-CAPRIN-1 therapeutic antibody Yuki MajimaDavid KryzaFumiyoshi Okano Research Open access 05 June 2025 Article: 184
Transcatheter arterial infusion chemotherapy combined with lipiodol chemoembolization for advanced gastric fundus and cardia cancer with obstruction Jiajia ZhangGang ZhouGang Wu Research Open access 05 June 2025 Article: 183
Fluorodeoxyglucose (FDG) PET/CT imaging analysis and clinical treatment evaluation in patients with SMARCA4-deficient tumors: case reports of four patients Xueqin ZhaoWei Fu Case Report Open access 03 June 2025 Article: 182
Clinical, therapeutic and prognostic differences between male and female patients with breast cancer—a comparison of 2510 men and 307,634 women in a registry-based study in Germany Marion GrafMichael GerkenElisabeth C. Sturm-Inwald Research Open access 03 June 2025 Article: 181
A prognostic PET radiomic model for risk stratification in non-small cell lung cancer: integrating radiogenomics and clinical features to predict survival and uncover tumor biology insights Parisa TaheriAaron Golden Research Open access 03 June 2025 Article: 180
Limited survival benefit in patients diagnosed with glioblastoma post-2016: a SEER population based registry analysis Shaurya DhingraMatthew KoshyMark Korpics Research Open access 02 June 2025 Article: 179
Microbiome in prostate cancer: pathogenic mechanisms, multi-omics diagnostics, and synergistic therapies Chengran WangTianqi DongJinlan Jiang Review Open access 31 May 2025 Article: 178
